269 related articles for article (PubMed ID: 16460044)
1. Targeted cross-linking of the human beta-globin gene in living cells mediated by a triple helix forming oligonucleotide.
Shahid KA; Majumdar A; Alam R; Liu ST; Kuan JY; Sui X; Cuenoud B; Glazer PM; Miller PS; Seidman MM
Biochemistry; 2006 Feb; 45(6):1970-8. PubMed ID: 16460044
[TBL] [Abstract][Full Text] [Related]
2. Enhancement and inhibition by 2'-O-hydroxyethyl residues of gene targeting mediated by triple helix forming oligonucleotides.
Kundu M; Nagatsugi F; Majumdar A; Miller PS; Seidman MM
Nucleosides Nucleotides Nucleic Acids; 2003 Oct; 22(10):1927-38. PubMed ID: 14609232
[TBL] [Abstract][Full Text] [Related]
3. Targeting of an interrupted polypurine:polypyrimidine sequence in mammalian cells by a triplex-forming oligonucleotide containing a novel base analogue.
Semenyuk A; Darian E; Liu J; Majumdar A; Cuenoud B; Miller PS; Mackerell AD; Seidman MM
Biochemistry; 2010 Sep; 49(36):7867-78. PubMed ID: 20701359
[TBL] [Abstract][Full Text] [Related]
4. Minimum number of 2'-O-(2-aminoethyl) residues required for gene knockout activity by triple helix forming oligonucleotides.
Puri N; Majumdar A; Cuenoud B; Natt F; Martin P; Boyd A; Miller PS; Seidman MM
Biochemistry; 2002 Jun; 41(24):7716-24. PubMed ID: 12056903
[TBL] [Abstract][Full Text] [Related]
5. Extensive sugar modification improves triple helix forming oligonucleotide activity in vitro but reduces activity in vivo.
Alam MR; Majumdar A; Thazhathveetil AK; Liu ST; Liu JL; Puri N; Cuenoud B; Sasaki S; Miller PS; Seidman MM
Biochemistry; 2007 Sep; 46(35):10222-33. PubMed ID: 17691818
[TBL] [Abstract][Full Text] [Related]
6. Importance of clustered 2'-O-(2-aminoethyl) residues for the gene targeting activity of triple helix-forming oligonucleotides.
Puri N; Majumdar A; Cuenoud B; Miller PS; Seidman MM
Biochemistry; 2004 Feb; 43(5):1343-51. PubMed ID: 14756571
[TBL] [Abstract][Full Text] [Related]
7. The development of bioactive triple helix-forming oligonucleotides.
Seidman MM; Puri N; Majumdar A; Cuenoud B; Miller PS; Alam R
Ann N Y Acad Sci; 2005 Nov; 1058():119-27. PubMed ID: 16394131
[TBL] [Abstract][Full Text] [Related]
8. Targeted gene knockout mediated by triple helix forming oligonucleotides.
Majumdar A; Khorlin A; Dyatkina N; Lin FL; Powell J; Liu J; Fei Z; Khripine Y; Watanabe KA; George J; Glazer PM; Seidman MM
Nat Genet; 1998 Oct; 20(2):212-4. PubMed ID: 9771719
[TBL] [Abstract][Full Text] [Related]
9. Triplex formation by oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine: decreased magnesium dependence and improved intracellular gene targeting.
Lacroix L; Lacoste J; Reddoch JF; Mergny JL; Levy DD; Seidman MM; Matteucci MD; Glazer PM
Biochemistry; 1999 Feb; 38(6):1893-901. PubMed ID: 10026270
[TBL] [Abstract][Full Text] [Related]
10. Pyrimidine motif triplexes containing polypurine RNA or DNA with oligo 2'-O-methyl or DNA triplex forming oligonucleotides.
Beban M; Miller PS
Biochim Biophys Acta; 2000 Jun; 1492(1):155-62. PubMed ID: 10858542
[TBL] [Abstract][Full Text] [Related]
11. Triple helix formation: binding avidity of acridine-conjugated AG motif third strands containing natural, modified and surrogate bases opposed to pyrimidine interruptions in a polypurine target.
Orson FM; Klysik J; Bergstrom DE; Ward B; Glass GA; Hua P; Kinsey BM
Nucleic Acids Res; 1999 Feb; 27(3):810-6. PubMed ID: 9889277
[TBL] [Abstract][Full Text] [Related]
12. Sequence and pH effects of LNA-containing triple helix-forming oligonucleotides: physical chemistry, biochemistry, and modeling studies.
Sun BW; Babu BR; Sørensen MD; Zakrzewska K; Wengel J; Sun JS
Biochemistry; 2004 Apr; 43(14):4160-9. PubMed ID: 15065859
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of T7 RNA polymerase transcription by phosphate and phosphorothioate triplex-forming oligonucleotides targeted to a R.Y site downstream from the promoter.
Alunni-Fabbroni M; Manfioletti G; Manzini G; Xodo LE
Eur J Biochem; 1994 Dec; 226(3):831-9. PubMed ID: 7813472
[TBL] [Abstract][Full Text] [Related]
14. Improved synthesis of daunomycin conjugates with triplex-forming oligonucleotides. The polypurine tract of HIV-1 as a target.
Capobianco ML; De Champdoré M; Arcamone F; Garbesi A; Guianvarc'h D; B Arimondo P
Bioorg Med Chem; 2005 May; 13(9):3209-18. PubMed ID: 15809156
[TBL] [Abstract][Full Text] [Related]
15. Formation of stable DNA triple helices within the human bcr promoter at a critical oligopurine target interrupted in the middle by two adjacent pyrimidines.
Xodo LE; Manzini G; Quadrifoglio F
Antisense Nucleic Acid Drug Dev; 1998 Dec; 8(6):477-88. PubMed ID: 9918112
[TBL] [Abstract][Full Text] [Related]
16. Gene targeting by triple helix-forming oligonucleotides.
Majumdar A; Puri N; McCollum N; Richards S; Cuenoud B; Miller P; Seidman MM
Ann N Y Acad Sci; 2003 Dec; 1002():141-53. PubMed ID: 14751832
[TBL] [Abstract][Full Text] [Related]
17. An efficient antigene activity and antiproliferative effect by targeting the Bcl-2 or survivin gene with triplex forming oligonucleotides containing a W-shaped nucleoside analogue (WNA-βT).
Taniguchi Y; Sasaki S
Org Biomol Chem; 2012 Oct; 10(41):8336-41. PubMed ID: 22987068
[TBL] [Abstract][Full Text] [Related]
18. Chromosome targeting at short polypurine sites by cationic triplex-forming oligonucleotides.
Vasquez KM; Dagle JM; Weeks DL; Glazer PM
J Biol Chem; 2001 Oct; 276(42):38536-41. PubMed ID: 11504712
[TBL] [Abstract][Full Text] [Related]
19. Effect of selective cytosine methylation and hydration on the conformations of DNA triple helices containing a TTTT loop structure by FT-IR spectroscopy.
Fang Y; Bai C; Wei Y; Lin SB; Kan L
J Biomol Struct Dyn; 1995 Dec; 13(3):471-82. PubMed ID: 8825727
[TBL] [Abstract][Full Text] [Related]
20. Purine- and pyrimidine-triple-helix-forming oligonucleotides recognize qualitatively different target sites at the ribosomal DNA locus.
Maldonado R; Filarsky M; Grummt I; Längst G
RNA; 2018 Mar; 24(3):371-380. PubMed ID: 29222118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
